The current prominent virus that induces severe acute respiratory syndrome is SARS-CoV-2.
The incidence of COVID-19 cases is increasing, necessitating the immediate development …

Although vaccination against SARS-CoV-2 infection has been initiated, effective therapies
for severe COVID-19 disease are still needed. A promising therapeutic strategy is using FDA …

Inhibitors of bromodomain and extra-terminal proteins (iBETs), including JQ-1, have been
suggested as potential therapeutics against SARS-CoV-2 infection. However, molecular …

The reason of significantly higher transmissibility of SARS Covid (2019 CoV-2) compared
with SARS Covid (2003 CoV) and MERS Covid (2012 MERS) can be attributed to mutations …

The less virulent human (h) coronaviruses (CoVs) 229E, NL63, OC43, and HKU1 cause
mild, self-limiting respiratory tract infections, while the more virulent SARS-CoV-1, MERS …

Pathogenesis by an infecting organism is a victory of pathogen infectivity on the targeted
host. It is often precipitated by the insufficiency of the host immune system to tackle the …

Since the emergence of the SARS-CoV-2 induced COVID-19 pandemic, millions of patients
have been diagnosed for the disease and many of them have died worldwide. SARS-CoV-2 …

The less virulent human (h) coronaviruses (CoVs) 229E, NL63, OC43, and HKU1 cause
mild, self-limiting respiratory tract infections, while the more virulent SARS-CoV-1, MERS …

Viruses undergo mutations over time, and sometimes these changes do not have any significant
impact on the virus's pro Page 1 African Journal of Biology and Medical Research ISSN …

Viroporins are a class of viral membrane proteins that play diverse roles in the viral infection
cycle. Viroporins are known to play roles in ion transport, inducing membrane curvature, as …